How long does it take for fertility to return after cancer treatment in men?

There is no single timeline. It is worth being clear about how little is published. The National Cancer Institute's page on male fertility says changes may be temporary or lasting. It gives no number of months or years for recovery. None.

One NCI summary does put figures on it. That is the summary of late effects in childhood cancer survivors. Those figures come with limits.

The numbers NCI does publish

In that summary, radiation that reached the testes drops sperm counts within 3 to 6 weeks. Recovery then depends on the dose. It may take 1 year, or more than 3.

Dose decides much of it. The tissue that makes sperm is called the germinal epithelium. It is harmed by much lower doses than the Leydig cells, which make testosterone. NCI's summary says lasting germ cell failure may occur above 2 to 4 Gy of split-dose radiation.

For chemotherapy, one drug class matters most: alkylating agents. NCI's page says they carry a high risk. They damage sperm and the cells that form sperm. The late effects summary adds published thresholds. Cyclophosphamide above 7.5 g/m² produced very low or absent sperm counts in most people exposed. So did ifosfamide above 60 g/m².

Drug combinations differ sharply. The same summary looks at ABVD, used in Hodgkin lymphoma. It often caused low or absent sperm counts during treatment. But sperm production came back afterward. Older MOPP-type regimens pair an alkylating agent with procarbazine. At high total doses, that damage was often permanent.

Those numbers come from people treated in childhood or adolescence. They describe a pattern, not a forecast for one person.

Why nobody can give a date

Eight factors sit behind the answer, and NCI lists them. The treatment used. The dose. How long it ran. Age at the time. How much time has passed since. The type of cancer, and whether the tumor sat near the reproductive organs. Fertility before any of this. And other health conditions.

Some effects are not about sperm at all. Surgery for prostate, testicular, penile, or bladder cancer can cause retrograde ejaculation. So can surgery for anal, colon, or rectal cancer. In that condition semen is made but not released. Radiation to the pelvis can damage the nerves and vessels needed for an erection. Radiation to the brain can affect the pituitary gland and hypothalamus. Those glands supply the hormones fertility depends on. Hormone therapy lowers sperm count directly.

Cancer itself is part of it. NCI notes that men with testicular, prostate, and other germ cell cancers sometimes have poor semen quality at diagnosis. Their sperm counts are low before treatment starts.

The test that gives a real answer

Blood tests such as FSH and inhibin B are often used to guess whether sperm production has resumed. NCI's summary is direct about their weakness. Their accuracy for this purpose has been questioned. Survivors should be told that semen analysis is the most accurate check.

So the practical route is a semen analysis, timed as the care team advises. Repeat it if the first is poor. A single low result is not a final answer.

Sperm banking before treatment remains the reliable hedge. NCI says frozen sperm can be stored for an indefinite time. Our guide to fertility in men after cancer treatment covers what changes, and the piece on fertility preservation before treatment covers the options before day one.

NCI's male fertility page was last updated on May 14, 2025.

Sources

• https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-men
• https://www.cancer.gov/types/childhood-cancers/late-effects-hp-pdq